Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediate l Side chain for pacltaxel & docetaxel
  Production management QC Quality System branch factory
 
logn  

username:

 password:

 

  home
 
  Products Center
  API
Paclitaxel (Natural) USP30
Paclitaxel Semi-Synthetic USP30
Docetaxel Anhydrous
Docetaxel Trihydrate
Irinotecan Hcl Trihydrate
Palonosetron Hydrochloride
Etoposide
Fludarabine phosphate
  Intermediate
10-DAB III(10-Deacetyl Baccatin III) 99%
Baccatin III 98%
9-DHB
Sequoyitol
Podophyllotoxin
4’-Demethyl-epi- Podophyllotoxin
5-Fluoroorotic Acid Hydrate
  Side chain for pacltaxel & docetaxel
(2R,3S)-3-Phenylisoserine Hydrochloride
(2R,3S)-N-benzoyl-3-Phenylisoserine Methyl Ester
(2R,3S)-N-tert-butoxycarbonyl-3-Phenyl isoserine methyl ester
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
   
Your location >>Home>>About us>>profile
 
 


Shanghai Jinhe Bio-technology Co., Ltd.is a high Bio-Tech private enterprise dedicated to developing, manufacturing and marketing Anti-Cancer APIs and their intermediates.

Jinhe was established in March 2002. Based on the R&D achievement of FUDAN university, at the beginning it launched the international business of processing Paclitaxel API. After several years of development, we become the largest processor on Taxus biomass in China. Furthermore, we successfully developed Docetaxel Anhydrous( Trihydrate), Irinotecan HCL Trihydrate, Etoposide and other products, developing Anti-cancer products from nature extracting to semi-synthetical Anti-cancer products. In recent two years we successfully developed Fludarabine Phosphate, Palonosetron Hydrochloride among others,products portfolio extending to broad-spectrum Anti-cancer drugs.

Since its establishment, we have been positioning our core value as specialization, aiming to go for internationalization, and striving to cultivate  own core competitiveness. Especially in respect of the effective use of Yew biomass and of the extraction, purification, synthesization of its active components, Jinhe has been in the leading position, possessing its own patented technique.

Our main products include Paclitaxel, Docetaxel Anhydrous( Trihydrate), Irinotecan Hcl Trihydrate, Etoposide, Fludarabine Phosphate, Palonosetron Hydrochloride, 10 DAB III, Podophyllotoxin etc. These products are mainly used for Anti-cancer drugs production, with a view to benefit the numerous cancer patients.

Jinhe’s headquarter is located in Liantang Industrial Park, Qingpu District, Shanghai, 50km away from Central Shanghai with convenient transportation. The branch-factory for extracting of biomass is in Yixing City, Jiangsu Province, Our R&D center is in Juke Biotech Park in Central Shanghai. Jinhe adheres to the "Good faith brings good luck, Harmonious cooperation brings long-term partner" business philosophy, and hope through our own development and innovation, Jinhe may bring more wealth to society and we will keep striving for Human health and happiness all the time.


   
CopyRight(C)2006,Shanghai Jinhe Bio-Technology Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE